Business
PV Nano Cell and Merck Sign a Supply Agreement for Sicrys
PV Nano Cell and Merck Sign a Supply Agreement for Sicrys.
About this update from Pv Nano Cell Ltd.
[{"type":"text","content":"- Validating Merck's Attempt for Using Single Crystal Metal Particles- Business Expected to Start in Q3 2018MIGDAL HA'EMEK, ISRAEL / ACCESSWIRE / July 2, 2018 / PV Nano Cell Ltd. (OTCQB: PVNNF), an innovative producer of single-crystal, metal nano metric based products and conductive digital inks which are also suitable for 3D printing, signed a supply agreement with Merck, a leading science and technology company. Supply quantities are targeted to ramp in 2018. This commercial agreement is a significant step for PV Nano Cell as its proprietary technology will be used by Merck in a wide range of diverse technology applications. Sales are expected to start immediately in Q3 2018.Today's announcement comes after several months of Merck and PV Nano Cell working together since its initial June 20, 2017 agreement for Cooperation for Development of Applications Utilizing Conductive Ink. https://ir.pvnanocell.com/press-releases/detail/21/pv-nano-cell-and-merck-enter-cooperation-for-development-of PV Nano Cell is the developer of the state-of-the-art Sicrys™ conductive inks based on single crystal nano particles of silver and copper. The performance material division of Merck is evaluating Sicrys single crystal metal particles with different, unique and patented technologies and applications. PV Nano Cell's Chief Executive Officer, Dr. Fernando de la Vega, commented ''We are excited to supply our Sicrys nano particles to Merck for their products. This is the second commercial agreement signed, within the last few months alone, with another major international group and it validates the unique position of PV Nano Cell in the mass production application market. The fact that Merck has chosen us, following a rigorous and comprehensive process, is an additional market recognition for our Sicrys™ unique products.''About MerckMerck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.Founded in 1668, Merck is the world's oldest pharmaceuti...